Challenges and Opportunities for Pharmacogenomics in the Care of People With Cystic Fibrosis
- 28 October 2025
- journal article
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (10) , e71358
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosisJournal of Cystic Fibrosis, 2024
- Pharmacogenetic actionability and medication prescribing in people with cystic fibrosisClinical and Translational Science, 2023
- Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic FibrosisPharmacogenomics, 2022
- Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelinesAmerican Journal of Health-System Pharmacy, 2022
- Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Genetics in Medicine, 2017
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011